Our findings also demonstrated that inhibition of SR-B1 in BCC lines is related to reduction of cellular cholesterol level and cell proliferation, which is consistent with the results of Danilo et al., 2013 in which down-regulation of SR-B1 in BCC had a relationship with the reduction of cholesterol content (27). This evidence concerns the gene SCARB1 and skin basal cell carcinoma.